P & G Health Ltd

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE199A01012
  • NSEID: PGHL
  • BSEID: 500126
INR
5,602.70
68 (1.23%)
BSENSE

Nov 20

BSE+NSE Vol: 24.41 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Standalone Half Yearly Results
Sep'25
Dec'24
Sep'24
Dec'23
Dec'22
Dec'21
Dec'20
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is 11.11%

stock-summary

Standalone Net Profit

Growth in half year ended Sep 2025 is 56.11%

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is 29.77%

stock-summary

Interest

Growth in half year ended Sep 2025 is -31.43%

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has improved from Sep 2024

Compare Half Yearly Results Of P & G Health Ltd With
Markets Mojo
Figures in Cr
Standalone Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
663.66
792.60
-128.94
-16.27%
Other Operating Income
0.00
0.00
0.00
Total Operating income
663.66
792.60
-128.94
-16.27%
Raw Material Cost
137.67
397.30
-259.63
-65.35%
Purchase of Finished goods
34.95
40.26
-5.31
-13.19%
(Increase) / Decrease In Stocks
-10.23
-67.81
57.58
84.91%
Employee Cost
109.89
84.13
25.76
30.62%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
180.77
169.60
11.17
6.59%
Total Expenditure (Excl Depreciation)
453.05
623.48
-170.43
-27.34%
Operating Profit (PBDIT) excl Other Income
210.61
169.12
41.49
24.53%
Other Income
8.98
4.74
4.24
89.45%
Operating Profit (PBDIT)
219.59
173.86
45.73
26.30%
Interest
0.24
17.46
-17.22
-98.63%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
219.35
156.40
62.95
40.25%
Depreciation
11.52
47.53
-36.01
-75.76%
Profit Before Tax
207.83
108.87
98.96
90.90%
Tax
53.11
26.72
26.39
98.76%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
154.72
82.15
72.57
88.34%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
154.72
82.15
72.57
88.34%
Equity Capital
16.60
45.32
-28.72
-63.37%
Face Value
10.00
5.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
93.20
9.06
84.14
928.70%
Diluted Earnings per share
93.21
9.05
84.16
929.94%
Operating Profit Margin (Excl OI)
31.73%
21.34%
0.00
10.39%
Gross Profit Margin
33.05%
19.73%
0.00
13.32%
PAT Margin
23.31%
10.36%
0.00
12.95%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 663.66 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 11.11%

Half Yearly - Standalone Net Profit
Standalone Net Profit 154.72 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 56.11%

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 210.61 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 29.77%

Half Yearly - Interest
Interest 0.24 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is -31.43%

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 31.73%
in Sep 2025

Figures in %
stock-summary

Growth in half year ended Sep 2025 has improved from Sep 2024